BridgeBio Pharma Inc (BBIO)

28.86 +0.60 (+2.14%) USD  |  NASDAQ  |  Jan 07, 16:00
28.83 -0.04 (-0.12%) After-Hours: 17:05
More

BridgeBio Pharma Research and Development Expense (Annual): 455.71M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Pfizer Inc 10.68B
Alnylam Pharmaceuticals Inc 1.004B
Cassava Sciences Inc 89.42M
Regeneron Pharmaceuticals Inc 4.439B
Biomarin Pharmaceutical Inc 746.77M